Terminated NA INTERVENTIONAL 1-arm NCT02275260

Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study

Reduction of AF Ablation Induced Thrombo-Embolic Incidence Pilot Study (REDUCE-TE Pilot)

Sponsor: Biotronik SE & Co. KG

Conditions Paroxysmal Atrial Fibrillation

Interventions Cerebral Diffusion-Weighted Magnetic Resonance Imaging Paperbased neurocognitive testing Transesophageal Echocardiography

Updated 12 times since 2017 Last updated: Oct 30, 2019 Started: Dec 31, 2014 Primary completion: Feb 8, 2017 Completion: Feb 15, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The required number of endpoints will be obtained with a sample size lower than initially planned.

Other terminated trials from Biotronik SE & Co. KG

See all terminations from Biotronik SE & Co. KG

Other Paroxysmal Atrial Fibrillation trials with similar outcome

Browse all Paroxysmal Atrial Fibrillation trials

This NA trial investigates Paroxysmal Atrial Fibrillation and is currently terminated or withdrawn. Biotronik SE & Co. KG leads this study, which shows 12 recorded versions since 2014 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

12 versions recorded

Sep 2025 — Present [monthly]

Terminated NA
Sep 2024 — Sep 2025 [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Dec 2021 — Jul 2024 [monthly]

Terminated NA
Jan 2021 — Dec 2021 [monthly]

Terminated NA

▶ Show 7 earlier versions

Nov 2020 — Jan 2021 [monthly]

Terminated NA
Dec 2019 — Nov 2020 [monthly]

Terminated NA
Jun 2018 — Dec 2019 [monthly]

Terminated NA
Dec 2017 — Jun 2018 [monthly]

Terminated NA
Nov 2017 — Dec 2017 [monthly]

Terminated NA
Apr 2017 — Nov 2017 [monthly]

Terminated NA

Status: Recruiting → Terminated
Jan 2017 — Apr 2017 [monthly]

Recruiting NA

First recorded

Dec 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biotronik SE & Co. KG
University Hospital Heidelberg

Data source: Biotronik SE & Co. KG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amsterdam, Netherlands , Bad Nauheim, Germany , Bad Oeynhausen, Germany , Berlin, Germany , Budapest, Hungary , Frankfurt am Main, Germany , Geneva, Switzerland , Leipzig, Germany , Munich, Germany , Prague, Czechia and 2 more locations